Recovery of BCS Class II drugs during aqueous redispersion of core-shell type nanocomposite particles produced via fluidized bed coating

Keyphrases

• Agglomeration 12%
• Agitation 12%
• Aqueous Surfactant Solutions 12%
• BCS Class II Drug 100%
• Carrier Particles 12%
• Complete Recovery 12%
• Core-shell Type 100%
• Dispersant 12%
• Dissolution Test 12%
• Drug Dissolution 12%
• Drug Nanoparticles 12%
• Fluidized Bed Coating 100%
• Fluidized Bed Processor 12%
• Griseofulvin 37%
• Hydroxypropyl Methylcellulose 37%
• Imaging Testing 12%
• Incomplete Recovery 12%
• Large Surface Area 12%
• Low Bioavailability 12%
• Mannitol 12%
• Media Milling 12%
• Nanocomposite Microparticles 37%
• Nanocomposite Particles 100%
• Nanoparticle Recovery 25%
• Nanoparticles 75%
• Nanosuspension 25%
• Particle Size Analysis 12%
• Phenylbutazone 12%
• Redispersion 100%
• SEM Imaging 12%
• Size Growth 12%
• Sodium Dodecyl Sulfate 50%
• Solid Dosage Form 25%
• Stabilizer 12%
• Surfactant 12%
• Synergistic Effect 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Bioavailability 11%
• Dispersant 11%
• Dosage Forms 22%
• Excipient 11%
• Griseofulvin 33%
• Hydroxypropyl Cellulose 33%
• Lactose 11%
• Mannitol 11%
• Microparticle 33%
• Nanocomposite 100%
• Nanoparticle 100%
• Phenylbutazone 11%
• Scanning Electron Microscopy 11%
• Sodium Dodecyl Sulfate 44%
• Surfactant 22%